During the past decade, Morrab Surgery conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Morrab Surgery" are "Cardiovascular Disease" (1 trials), "Gastro-Intestinal Tolerance" (1 trials) and "Gastrointestinal Tolerance" (1 trials). Many other conditions were trialed in "Morrab Surgery" in a lesser frequency.

Most popular intervention types in "Morrab Surgery" are "Other" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Experimental Nutritional Pudding" (1 trials), "High Protein, Energy Dense Nutritional Supplement" (1 trials), "Placebo" (1 trials) and "bococizumab (PF-04950615)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Morrab Surgery" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Morrab Surgery". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Morrab Surgery, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Morrab Surgery, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".